Brief: Shoulder Innovations Receives FDA 510(K) Clearance For N-22 Humeral Head And Initiates Full Commercial Launch
10/09/2026 21:21
BRIEF-Shoulder Innovations Receives FDA 510(K) Clearance For N-22 Humeral Head And Initiates Full Commercial Launch Sept 10 (Reuters) - Shoulder Innovations, Inc. SI.N:
SHOULDER INNOVATIONS RECEIVES FDA 510(K) CLEARANCE FOR N-22 HUMERAL HEAD AND INITIATES FULL COMMERCIAL LAUNCH
Source text: ID:nPn2Hy5W3a
Further company coverage: SI.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shoulder Innovations
See all newsBrief: Shoulder Innovations Receives FDA 510(K) Clearance For N-22 Humeral Head And Initiates Full Commercial Launch
Shoulder Innovations, Inc. reports results for the quarter ended June 30 - Earnings Summary
Shoulder Innovations, Inc. expected to post a loss of 46 cents a share - Earnings Preview
Brief: Shoulder Innovations Reports First Quarter 2026 Financial Results And Raises Full Year Outlook
Shoulder Innovations beats Q1 revenue estimates, lifts 2026 revenue forecast